Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients Ugo TestaFrancesco Lo-Coco Review Article 26 February 2016 Pages: 673 - 680
Tyrosine kinase inhibitors in Ph+ acute lymphoblastic leukaemia: facts and perspectives Michele MalagolaCristina PapayannidisMichele Baccarani Review Article 19 February 2016 Pages: 681 - 693
Prognostic value of pretransplant FDG-PET in refractory/relapsed Hodgkin lymphoma treated with autologous stem cell transplantation: systematic review and meta-analysis Hugo J. A. AdamsThomas C. Kwee Review Article Open access 02 March 2016 Pages: 695 - 706
Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis and Hemostasis Research (GTH) Iris AppelmannStephan KreherSteffen Koschmieder Review Article 26 February 2016 Pages: 707 - 718
Current opinion and consensus statement regarding the diagnosis, prognosis, and treatment of patients with essential thrombocythemia: a survey of the Spanish Group of Ph-negative Myeloproliferative Neoplasms (GEMFIN) using the Delphi method C. BessesJ. C. Hernández-Boludaon behalf of GEMFIN Original Article 22 February 2016 Pages: 719 - 732
Pegylated interferon for the treatment of early myelofibrosis: correlation of serial laboratory studies with response to therapy Caitlin O’NeillImran SiddiqiCasey O’Connell Original Article 10 March 2016 Pages: 733 - 738
Sensitive and accurate quantification of JAK2 V617F mutation in chronic myeloproliferative neoplasms by droplet digital PCR Miguel WaterhouseMarie FolloJürgen Finke Original Article 01 March 2016 Pages: 739 - 744
Evaluation of clinicopathologic characteristics and the BRAF V600E mutation in Erdheim-Chester disease among Chinese adults Xin-xin CaoJian SunDao-bin Zhou Original Article 09 February 2016 Pages: 745 - 750
Serum zinc levels in patients with iron deficiency anemia and its association with symptoms of iron deficiency anemia Engin KelkitliNurinnisa OzturkEbubekir Bakan Original Article 02 March 2016 Pages: 751 - 756
Longitudinal changes of endocrine and bone disease in adults with β-thalassemia major receiving different iron chelators over 5 years Maurizio PoggiFrancesco SorrentinoVincenzo Toscano Original Article 09 March 2016 Pages: 757 - 763
Rituximab is an effective and safe treatment of relapse in elderly patients with resistant warm AIHA Kamel LaribiDelphine BolleAlix Baugier de Materre Original Article 09 February 2016 Pages: 765 - 769
Cyclosporine restores hematopoietic function by compensating for decreased Tregs in patients with pure red cell aplasia and acquired aplastic anemia An T. T. DaoHirohito YamazakiShinji Nakao Original Article 11 March 2016 Pages: 771 - 781
Leukemogenic potency of the novel FLT3-N676K mutant Kezhi HuangMin YangZhixiong Li Original Article 19 February 2016 Pages: 783 - 791
Characteristics and outcome of patients with primary CNS lymphoma in a “real-life” setting compared to a clinical trial Vanja ZeremskiMichael KoehlerEnrico Schalk Original Article 23 January 2016 Pages: 793 - 799
Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma Ji Hyun ParkDok Hyun YoonCheolwon Suh Original Article 17 February 2016 Pages: 801 - 808
Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era Azim JalaliFrancis J. HaEliza A. Hawkes Original Article 15 February 2016 Pages: 809 - 816
A comprehensive approach to the prevention of central venous catheter complications: results of 10-year prospective surveillance in pediatric hematology-oncology patients Simone CesaroMara CavaliereGloria Tridello Original Article 10 March 2016 Pages: 817 - 825
Clinical profile of megaloblastic anemia in China: a single center experience from MegA-1710 program over two decades Zhendong HuangJun ShiYizhou Zheng Letter to the Editor 12 February 2016 Pages: 827 - 828
A nationwide survey of co-occurrence of malignant lymphomas and myelodysplastic syndromes/myeloproliferative neoplasms Mamiko Sakata-YanagimotoYasuhisa YokoyamaShigeru Chiba Letter to the Editor 19 February 2016 Pages: 829 - 830
A Japanese pedigree with a p.A95V mutation in the MYH9 gene demonstrates inherited macrothrombocytopenia without Alport manifestations Setsuri YokoiShinji KunishimaSeiji Kojima Letter to the Editor 10 February 2016 Pages: 831 - 833
Severe Helicobacter pylori gastritis-related thrombocytopenia and iron deficiency anemia in an adolescent female Kimito TodoTadaki OhmaeShinsaku Imashuku Letter to the Editor 09 March 2016 Pages: 835 - 836
Relapsed and refractory subcutaneous panniculitis-like T-cell lymphoma with excellent response to cyclosporine: a case report and literature review Chi-Ching ChenChieh-Lin TengSu-Peng Yeh Letter to the Editor 13 February 2016 Pages: 837 - 840
Spontaneous regression of adult T cell leukemia/lymphoma following development of immune thrombocytopenia Hiroshi UreshinoMasaharu Miyahara Letter to the Editor 29 February 2016 Pages: 841 - 843
Solitary plasmablastic lymphoma in the esophagus Keichiro MiharaNaomi SasakiShinichi Suehiro Letter to the Editor 01 March 2016 Pages: 845 - 846
Complete remission of refractory disseminated NK/T cell lymphoma with brentuximab vedotin and bendamustine Li-Mei PoonYok-Lam Kwong Letter to the Editor 02 March 2016 Pages: 847 - 849
Erratum to: Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years’ follow-up in Egypt Amal El-BeshlawyMona El-GhamrawyAmina Abdel-Salam Erratum 14 March 2016 Pages: 851 - 851